Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
1,137
currently held
Exits tracked
410
hand-checked
Sectors covered
1
across the portfolio
Countries covered
38
from every market
1,419 companies matching · Page 27 of 29
Osivax
CapHorn 2
FranceSector
Biotech
InvestorCapHorn
Entry
–
Oxford Cancer Analytics
Eka Ventures Fund I
UKSector
Biotech
InvestorEKA Ventures
Entry
2022
Hold
4yr
Oxolife
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2020
Hold
6yr
PAGE Therapeutics AG
KIZOO Evergreen (Balance Sheet)
SwitzerlandSector
Biotech
InvestorKIZOO Technology Capital
Entry
2023
Hold
3yr
PALUMED S.A
IRDInov 3
FranceSector
Biotech
InvestorIrdi Capital-Investissement
Entry
2002
Pathalys Pharma
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2023
Hold
3yr
PDS Biotechnology
EMV Capital Evergreen Fund
United StatesSector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
PEP-Therapy
CapHorn 2
FranceSector
Biotech
InvestorCapHorn
Entry
–
Pepkon
Aloe Environment Fund III
FranceSector
Biotech
InvestorAloe Private Equity
Entry
2019
Hold
7yr
PEPperPRINT
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2010
Hold
16yr
PeptiSystems
Almi Invest (Regional funds)
SwedenSector
Biotech
InvestorAlmi Invest
Entry
2019
Hold
7yr
Pergamum
Rosetta Capital IV
SwedenSector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Persea
Erganeo
FranceSector
Biotech
InvestorErganeo
Entry
2022
Hold
4yr
Phaeosynt GmbH
NBank Capital Beteiligungsfonds
GermanySector
Biotech
InvestorNBank Capital
Entry
2025
Hold
1yr
Pharmability
Almi Invest (Regional funds)
SwedenSector
Biotech
InvestorAlmi Invest
Entry
2020
Hold
6yr
Pharmacelera
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2026
Hold
0yr
Pixelgen
Navigare Ventures
SwedenSector
Biotech
InvestorNavigare Ventures
Entry
2022
Hold
4yr
Pixelgen Technologies
Industrifonden Evergreen
SwedenSector
Biotech
InvestorIndustrifonden
Entry
2023
Hold
3yr
PL BioScience
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
GermanySector
Biotech
InvestorD11Z. Ventures
Entry
2021
Hold
5yr
Polygon Therapeutics
Sorbonne Venture by Audacia
FranceSector
Biotech
InvestorAudacia
Entry
2024
Hold
2yr
Polyphron
Vento Fund II
United StatesSector
Biotech
InvestorVento
Entry
2025
Hold
1yr
Portal Biotech
Earlybird Health
United KingdomSector
Biotech
InvestorEarlybird Venture Capital
Entry
2025
Hold
1yr
PreOmics
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Priothera Ltd.
HealthCap VII
IrelandSector
Biotech
InvestorHealthCap
Entry
2020
Hold
6yr
Prokarium
Flerie Invest
United KingdomSector
Biotech
InvestorFlerie
Entry
2014
Hold
12yr
Promatix
ALSA Ventures European Biotechnology Fund
UKSector
Biotech
InvestorALSA Ventures
Entry
2021
Hold
5yr
ProteomEdge
Navigare Ventures
SwedenSector
Biotech
InvestorNavigare Ventures
Entry
2025
Hold
1yr
Proteon...
Health for Life Capital
Poland
Sector
Biotech
InvestorSeventure Partners
Entry
2022
Hold
4yr
Proteos Biotech
Tresmares Private Equity Fund II
SpainSector
Biotech
InvestorTresmares Capital
Entry
2023
Hold
3yr
ProTgen
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
PsiOxus Therapeutics
Rosetta Capital V
UKSector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Pulmobiotics
Invivo Ventures
SpainSector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
QBio JRC
Elaia Endowment Fund
FranceSector
Biotech
InvestorElaia Partners
Entry
2022
Hold
4yr
QUANTRO Therapeutics
Boehringer Ingelheim Venture Fund
AustriaSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
R1 Therapeutics
Abingworth Bioventures IX
USSector
Biotech
InvestorAbingworth
Entry
2026
Hold
0yr
Rampart Biosciences
HealthCap VIII
United StatesSector
Biotech
InvestorHealthCap
Entry
2023
Hold
3yr
Rarity Bioscience
Navigare Ventures
SwedenSector
Biotech
InvestorNavigare Ventures
Entry
2022
Hold
4yr
Rathlin Therapeutics
Columbus Life Sciences Fund IV
United KingdomSector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr
Re-Vana Therapeutics Ltd
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2016
Hold
10yr
Recursion
Mubadala Capital Other Investments
United StatesSector
Biotech
InvestorMubadala Capital
Entry
–
Recurv Pharma, Inc.
TVM Life Science Innovation
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Redx Pharma
Sofinnova Crossover Fund I
United KingdomSector
Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
ReiThera S.r.l.
Fondo Salvaguardia Imprese
ItalySector
Biotech
InvestorInvitalia
Entry
2021
Hold
5yr
ReNewVax
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2025
Hold
1yr
Repron Therapeutics
Claris Biotech I
ItalySector
Biotech
InvestorClaris Ventures SGR
Entry
2023
Hold
3yr
Reservoir Neuroscience
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2024
Hold
2yr
Retein
Navigare Ventures
SwedenSector
Biotech
InvestorNavigare Ventures
Entry
2023
Hold
3yr
RheumaLogics
Novo Holdings Seed Investments
DenmarkSector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
Ribonexus
AFB Fund II
FranceSector
Biotech
InvestorAdBio Partners
Entry
2021
Hold
5yr
RiboX Therapeutics
Boehringer Ingelheim Venture Fund
China
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2021
Hold
5yr